<DOC>
	<DOCNO>NCT02188173</DOCNO>
	<brief_summary>This study OZURDEX® use clinical practice patient diabetic macular edema ( DME ) .</brief_summary>
	<brief_title>An Observational Study OZURDEX® Diabetic Macular Edema ( DME )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Diagnosis DME least one eye treat OZURDEX® per clinical practice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>